Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Chang Yingjun

Clinical trials sponsored by Chang Yingjun, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New CAR-T therapy targets antibodies blocking Life-Saving transplants Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

New CAR-T therapy targets antibodies blocking Life-Saving transplants

Disease control Not yet recruiting

This early-stage study tests a new treatment using special immune cells (CAR-T cells) designed to reduce harmful antibodies that can prevent or damage bone marrow transplants. About 18 people with blood diseases who have these antibodies will receive the cells in increasing doses…

Phase 1/2 • Sponsor: Chang Yingjun • Aim: Disease control

Last updated Jun 27, 2026 09:10 UTC